| Financial Year |
March 31 2023 |
| Monetary Funds |
49,422,302.97 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
139,547,662.41 |
| Advances to Suppliers |
2,228,870.08 |
| Other Receivables |
3,654,790.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
124,965,536.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,505,503.41 |
| Total Current Assets |
406,457,675.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
407,590,814.14 |
| Under-construction Projects |
37,170,203.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
49,072,580.53 |
| R&D expenses |
-- |
| Goodwill |
40,931,815.72 |
| Long-Term Deferred and Prepaid Expenses |
7,861,432.10 |
| Deferred Income Tax Assets |
26,278,715.06 |
| Other Non-Current Assets |
19,769,340.35 |
| Sub-Total of Non-Current Assets |
599,153,924.15 |
| Total Assets |
1,005,611,600.04 |
| Short-Term Loans |
40,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
65,014,029.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,920,208.32 |
| Taxes Payable |
7,292,276.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,559,908.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
145,781,981.94 |
| Long-term Loans |
40,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
504,364.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
45,418,173.99 |
| Total Liabilities |
191,200,155.93 |
| Paid-In Capital(Or Share Stock) |
270,140,605.00 |
| Capital Surplus |
109,958,688.56 |
| Surplus Reserve |
51,155,882.61 |
| LESS:Treasury Stock |
24,385,562.82 |
| Undistributed Profits |
407,541,830.76 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
814,411,444.11 |
| Owner's Equity（Stockholder's Equity） |
814,411,444.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,005,611,600.04 |
